The Global Alopecia Market Size accounted for USD 8,379 Million in 2021 and is estimated to achieve a market size of USD 16,760 Million by 2030 growing at a CAGR of 8.2% from 2022 to 2030. Sedentary lifestyles with poor diets, as well as the increasing prevalence of areata and androgenic alopecia around the world, are the key drivers driving the global alopecia market growth. Furthermore, the increased incidences of hair loss, as well as technological developments in alopecia treatments, are propelling the global alopecia market value.

Alopecia Market Report Key Highlights

• Global alopecia market revenue is expected to increase by USD 16,760 Million by 2030, with a 8.2% CAGR from 2022 to 2030
• North America region led with more than 36% of alopecia market share in 2021
• Asia-Pacific alopecia motor market growth will observe strongest CAGR from 2022 to 2030
• By disease type, the alopecia areata segment has accounted market share of over 35% in 2021
• By distribution channel, prescription segment engaged more than 66% of the total market share in 2021
• Rising alopecia prevalence on a global scale, drives the alopecia market size

Alopecia refers to the loss of hair from parts of the head or body. A sedentary lifestyle and unhealthy diets are leading loss of hair among the masses. Hormonal miss proportion and aging contribute to rising cases of hair loss. The overall rise in the geriatric population and rising awareness and preference for surgical hair transplants and other such treatments also have a positive influence on the global market in the forecast period.

Global Alopecia Market Trends

Market Drivers

• Rising alopecia prevalence on a global scale
• Increase in global health spending
• Growing incidence of chronic diseases
• Technological advancements in alopecia therapy

Market Restraints

• A lack of reimbursement rules for alopecia treatment
• Rising adoption of alternatives

Market Opportunities

• Adoption of innovative technologies in the treatment of alopecia
• Increasing number of proposals are being performed by organizations

Alopecia Market Report Coverage

Market	Alopecia Market
Alopecia Market Size 2021	USD 8,379 Million
Alopecia Market Forecast 2030	USD 16,760 Million
Alopecia Market CAGR During 2022 - 2030	8.2%
Alopecia Market Analysis Period	2018 - 2030
Alopecia Market Base Year	2021
Alopecia Market Forecast Data	2022 - 2030
Segments Covered	By Disease Type, By Distribution Channel, By End Users, And By Geography
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled	Cipla, Dr. Reddy’s Laboratories Ltd, Merck & Co., Viviscal, Regaine, Ranbaxy Laboratories Ltd, Kirkland Signature, Lexington International LLC, Vitabiotics, Alpecin - Dr. Kurt Wolff GmbH & Co, Johnson and Johnson, and GlaxoSmithKline PLC.
Report Coverage	Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Alopecia Market Dynamics

Product developments are expected to drive market growth in the near future. Recent product development such as the introduction of rapidly acting JAK drugs approved by the U.S. Food and Drug Administration (FDA), developments of methods to stimulate hair growth using human pluripotent stem cells, development of PRP treatment, the introduction of a new drug SM04554 which Specifically which stimulate hair growth in men are driving factors. Technological advancements and products like Hairmax Laser Comb, Follinex Massager Comb, Lifemax Infrared Hair Brush and Hair Growth Renewing lasers are some of the products built on advanced technology. The launch of new drugs and the treatment success rate and the clinical outcomes are some of the biggest drives.

The global alopecia market is segmented on the basis of types, end users, and distribution channels. On the basis of disease type, the global market is segmented into alopecia areata and androgenetic alopecia. On the basis of end users, the market is segmented into homecare settings, dermatology clinics, and others. And on the basis of distribution channels, the market is categorized into prescriptions and OTC.

Alopecia Market Segmentation

The global alopecia market segmentation is based on disease type, distribution channel, end users, and geography.

Alopecia Market By Disease Type

• Alopecia Areata
• Androgenetic Alopecia
• Cicatricial Alopecia
• Alopecia Universalis
• Alopecia Totalis
• Traction Alopecia
• Other

According to an alopecia industry analysis, the alopecia areata disease type segment held a considerable market share in 2021. This expansion is being driven by increasing disease incidence and rising consumer consciousness among sufferers. The segment is expected to rise at a rapid pace during the projected period, due to a surge in the creation of novel therapies and positive measures in the regulatory process. The increasing disease frequency around the world, as well as increased consumer awareness about therapies, are driving expansion. Furthermore, baldness is more common in persons who have autoimmune illnesses. Moreover, due to the emergence of numerous potential pipeline prospects and strong growth in the estimated incidence, the androgenetic alopecia segment is predicted to develop at the fastest rate.

Alopecia Market By Distribution Channel

• Prescriptions
• OTC

In terms of distribution channels, the prescription segment leads the global alopecia market in 2021. Various factors supporting segment expansion include cost-effective therapy, convenient access to medicines, and a growing amount of drug approvals. Furthermore, a solid product portfolio, rising discretionary income, and the increased incidence of chronic conditions that cause hair loss are likely to drive the segment's quickest growth throughout the projection period.

Alopecia Market By End Users

• Homecare Settings
• Dermatology Clinics
• Other

According to the alopecia market forecast, the dermatology clinics segment led the global market and contributed to the largest revenue portion over the projected timeframe. Dermatology clinics hire experienced specialist doctors who are trained to diagnose scalp and hair problems. Dermatologists can help determine the root cause of hair problems and efficiently cure hair fall in a variety of situations. Dermatology centers have a sizable share of the market due to the growing number of treatments associated with hair restoration and reinstatement, as well as the extensive use of prescription medications. Health centers have the knowledge to both prevent and encourage hair growth.

Alopecia Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)